Compare MSAI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSAI | BNGO |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7M | 13.3M |
| IPO Year | N/A | 2018 |
| Metric | MSAI | BNGO |
|---|---|---|
| Price | $5.38 | $1.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $110.00 | $7.00 |
| AVG Volume (30 Days) | ★ 331.3K | 133.8K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000,735.00 |
| Revenue This Year | $98.45 | $14.99 |
| Revenue Next Year | $38.89 | $34.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.15 | $1.06 |
| 52 Week High | $7.94 | $5.50 |
| Indicator | MSAI | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 47.44 | 38.97 |
| Support Level | $0.31 | $1.09 |
| Resistance Level | $6.92 | $1.18 |
| Average True Range (ATR) | 0.47 | 0.04 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 57.10 | 0.00 |
MultiSensor AI Holdings Inc builds and deploys integrated condition monitoring and early threat detection solutions through a unified edge-to-cloud software architecture, delivering AI-powered connected intelligence and analytics for asset reliability and performance. The Company's platform integrates multiple sensing modalities such as thermal, visual, and vibration to detect mechanical, electrical, and other modes of asset failure, enabling organizations operating high-throughput, automation-rich, and power-dense facilities to protect uptime, enhance safety, and extend the useful life of their critical assets.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.